Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...

While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...

Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...

Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

paid $200 a month for compounded drugs for obesity that were produced by her local pharmacy. She is on Medicare, which generally will not pay for Wegovy or Zepbound. The Trump administration ...

The South Korean office of the Danish pharmaceutical company Novo Nordisk recently requested the local authorities to permit the use of its anti-obesity medication Wegovy for children aged 12 and ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...